Manage Your Liver
Q:

I was diagnosed with chronic hepatitis C, but I don’t feel any abnormalities and my liver function test results are also normal. Why is this? Do I require treatment and what kind?

A:

This phenomenon is actually quite common. Hepatitis C virus (HCV) causes damage to the liver by first evading the immune system and then attacking the liver cells, leading to hepatitis (inflammation of the liver). When liver cells are attacked, liver function will be affected and become abnormal. However, if a person infected with HCV has strong immunity and is able to generate a strong cellular immune response against the virus, the virus will not be able to damage liver cells and affect liver function. [1]

 

People often think that when hepatitis virus is present in the body, the liver will be damaged and that the higher the viral count, the more severe the damage. This is a misconception. The amount of HCV RNA present in blood should not be used to measure the degree of damage in liver cells. A high viral load does not imply serious liver damage, similarly, a low viral count does not equal little liver injury. [2]

 

If patients infected with HCV have normal liver function (regardless of viral load), there is no rationale for treatment. [3][4] (The decision should be made based on taking together all laboratory data and overall health factors such as HCV viral load, liver enzymes, age, etc.) However, patients must ensure and maintain strong immunity and monitor liver health and function by having regular checkups.

 

Patients should pay attention to their ALT & AST levels, as these enzymes are commonly used as indicators of liver injury. When these enzymes are within the normal range, there is a high possibility that liver function is normal. But in some cases, these enzyme levels may also be within the normal range even in the presence of liver damage, e.g. cirrhosis. Therefore, patients should look at the overall results of Liver Function Tests (LFTs) to assess the general state of the liver.

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
About 2.7 million persons in the United States are infected with hepatitis C virus in their blood. The majority of these individuals remain asymptomatic for many years following the initial infection, and many people can even live their whole life with hepatitis C virus in their body without knowing they are infected. On the other hand, some carriers will develop chronic hepatitis C, meaning that the virus in their body attacks the liver, causing liver damage with elevated alan
A:
Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hep
Hit Questions
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us